Complex dynamics and stability of resistance to antimalarial drugs

Article English OPEN
Hastings, Ian (2006)

A succession of antimalarial drugs has been deployed to treat human falciparum malaria but each has, in turn, been nullified by the spread of drug resistance. The consensus view has always been that, once present, resistance will inevitably rapidly increase to 100%. However, recent field evidence has shown this is not inevitable, and that drug resistance may initially spread and then stabilize at relatively low frequencies. It is proposed that intense competition between separate malaria clones co-infecting the same human can generate complex dynamics capable of explaining this observation. Standard Population genetic analysis confirms this assertion. The dynamics underlying the evolution of antimalarial resistance may therefore be much more complex than previously realized, and can resolve the apparent paradox between field data and the underlying theory of the evolution of resistance. This explanation is novel and the results are equally applicable to other parasitic species where multiple infections of the same host are common.
  • References (58)
    58 references, page 1 of 6

    Anderson, R. M. and May, R. M. (1992). Infectious Diseases of Humans. Oxford University Press, Oxford.

    Anderson, T. J. C., Haubold, B., Williams, J. T., Estrada-Franco, J. G., Richardson, L., Mollinedo, R., Bockarie, M., Mokili, J., Mharakurwa, S., French, N., Whitworth, J., Velez, I. D., Brockman, A. H., Nosten, F., Ferreira, M. U. and Day, K. P. (2000). Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Molecular Biology and Evolution 17, 1467-1482.

    Anderson, T. J. C. and Roper, C. (2005). The origins and spread of antimalarial drug resistance : lessons for policy makers. Acta Tropica 94, 269-280.

    Ariey, F., Duchemin, J.-B. and Robert, V. (2003). Metapopulation concepts applied to falciparum malaria and their impacts on the emergence and spread of chloroquine resistance. Infection, Genetics and Evolution 2, 185-192.

    Arnot, D. E. (1998). Clone multiplicity of Plasmodium falciparum infections in individuals exposed to variable levels of disease transmission. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 580-585.

    Awadzi, K., Boakye, D. A., Edwards, G., Opoku, N. O., Attah, S. K., Osei-Atweneboana, M. Y., LazdinsHelds, J. K., Ardrey, A. E., Addy, E. T., Quartey, B. T., Ahmed, K., Boatin, B. A. and Soumbey-Alley, E. W. (2004). An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Annals of Tropical Medicine and Parasitology 98, 231-249.

    Babiker, H. A., Satti, G., Ferguson, H., Bayoumi, R. and Walliker, D. (2005). Drug resistant Plasmodium falciparum in an area of seasonal transmission. Acta Tropica 94, 260-268.

    Coleman, P. G., Morel, C., Shillcutt, S., Goodman, C. and Mills, A. J. (2004). A threshold analysis of the costeffectiveness of artemisinin-based combination therapies in sub-Saharan Africa. American Journal of Tropical Medicine and Hygiene 71 (Suppl. 2), 196-204.

    Coles, G. C., Bruce, J. I., Kinoti, G. K., Mutahi, W. T., Dias, L. C. S., Rocha, R. S. and Katz, N. (1987). The Potential for Drug resistance in Schistosomiasis. Parasitology Today 3, 349-350.

    Cortese, J. F., Caraballo, A., Contreras, C. E. and Plowe, C. V. (2002). Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. Journal of Infectious Diseases 186, 999-1006.

  • Metrics
    views in OpenAIRE
    views in local repository
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    LSTM Online Archive - IRUS-UK 0 31
Share - Bookmark